These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 26163596)

  • 21. Diagnostic and Prognostic Value of Serum MicroRNA-206 in Patients with Gastric Cancer.
    Hou CG; Luo XY; Li G
    Cell Physiol Biochem; 2016; 39(4):1512-20. PubMed ID: 27614739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the molecular diagnostics of gastric cancer.
    Kanda M; Kodera Y
    World J Gastroenterol; 2015 Sep; 21(34):9838-52. PubMed ID: 26379391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
    Shekari N; Baradaran B; Shanehbandi D; Kazemi T
    Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review.
    Deng Z; Wu J; Xu S; Chen F; Zhang Z; Jin A; Wang J
    Biomark Med; 2020 Feb; 14(2):141-150. PubMed ID: 32064893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of miR‑34 in gastric cancer: From bench to bedside (Review).
    Xiong S; Hu M; Li C; Zhou X; Chen H
    Oncol Rep; 2019 Nov; 42(5):1635-1646. PubMed ID: 31432176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA analysis of gastric cancer patients from Saudi Arabian population.
    Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
    BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of miRNA and RNA functions as potential biomarkers for gastric cancer.
    Chen S; Zhu J; Yu F; Tian Y; Ma S; Liu X
    Tumour Biol; 2015 Dec; 36(12):9909-18. PubMed ID: 26168960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating microRNAs as Potential Diagnostic Biomarkers and Therapeutic Targets in Gastric Cancer: Current Status and Future Perspectives.
    Mirzaei H; Khataminfar S; Mohammadparast S; Sales SS; Maftouh M; Mohammadi M; Simonian M; Parizadeh SM; Hassanian SM; Avan A
    Curr Med Chem; 2016; 23(36):4135-4150. PubMed ID: 27538692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiRNA as potential biomarkers and therapeutic targets for gastric cancer.
    Shin VY; Chu KM
    World J Gastroenterol; 2014 Aug; 20(30):10432-9. PubMed ID: 25132759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in gastric cancer metastasis.
    Shi Z; Wei Q; She J
    Crit Rev Eukaryot Gene Expr; 2014; 24(1):39-53. PubMed ID: 24579669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
    Huang YK; Yu JC
    World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of microRNAs in gastric cancer.
    Ishiguro H; Kimura M; Takeyama H
    World J Gastroenterol; 2014 May; 20(19):5694-9. PubMed ID: 24914330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Deregulation of microRNAs in gastric cancer: up regulation by miR-21 and miR-106].
    Arias Sosa LA; Cuspoca Orduz AF; Bernal Gómez BM
    Rev Gastroenterol Peru; 2017; 37(1):65-70. PubMed ID: 28489839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma miR-940 may serve as a novel biomarker for gastric cancer.
    Liu X; Kwong A; Sihoe A; Chu KM
    Tumour Biol; 2016 Mar; 37(3):3589-97. PubMed ID: 26456959
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Expression of
    Obermannova R; Redova-Lojova M; Vychytilova-Faltejskova P; Grell P; Cho WC; Sachlova M; Svoboda M; Vyzula R; Slaby O
    Anticancer Res; 2018 Jun; 38(6):3719-3724. PubMed ID: 29848733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs in gastric cancer: from bench to bedside.
    Hu ML; Xiong SW; Zhu SX; Xue XX; Zhou XD
    Neoplasma; 2019 Mar; 66(2):176-186. PubMed ID: 30509106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical crosstalk between microRNAs and gastric cancer (Review).
    Ouyang J; Xie Z; Lei X; Tang G; Gan R; Yang X
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives.
    Link A; Kupcinskas J
    World J Gastroenterol; 2018 Aug; 24(30):3313-3329. PubMed ID: 30122873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
    Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
    Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
    Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
    Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.